Dianne Chadwick, PhD oversees the operations of the University Health Network (UHN) BioBank. Previously, she received her PhD in Medical Biophysics from the University of Toronto, and completed a fellowship in Clinical Laboratory Genetics.
Since joining the UHN Biobank 6 years ago, Dr. Chadwick has played an active role in the growth and transformation of the UHN Biobank into an institutional Core Facility supporting clinical and translational research in oncology, multi-organ transplant, cardiovascular, infectious and other diseases. Her research interest is focused on quality assurance in Biobanking. She has co-authored at review as well as several peer-reviewed publications, and has been an invited speaker at conferences in Canada, US, Qatar and China. Dr. Chadwick looks forward to sharing her Biobanking experience at the 2017 Ontario Association of Pathologists’ meeting.
Dr. K. Chorneyko is a pathologist and medical laboratory director at Brant Community Healthcare System and West Haldimand Hospital. Trained in anatomical and general pathology, she has worked in both academic and community laboratory environments. She is a former Royal College examiner in Anatomical Pathology and is currently working with Royal College International as co-chair of the Kuwait Anatomical Pathology exam. She is past president of Brant County Medical Association and the Ontario Association of Pathologists (OAP). She has been involved with Path2Quality for many years contributing to both the Standards2Quality and Work2Quality documents as well as other Path2Quality initiatives. She is an anatomical pathology immunohistochemistry assessor for the Institute for Quality Management in HealthCare (IQMH) program and an Ontario Laboratory Accreditation assessor. She works with the Canadian Society for Medical Laboratory Science (CSMLS) as a cytology exam panel member. She has been the QMP pathology clinical lead since 2013.
Dr. Christine Collier did her undergraduate and graduate training at the University of Toronto and at the Hospital for Sick Children. Following her postdoctoral fellowship in Clinical Biochemistry at the University of Manitoba, she did a year of post-doctoral research with Dr. J. Bertino at the Memorial Sloan-Kettering Cancer Center in New York City. While at Kingston General Hospital and Queen’s University for the last 28 years, she was involved with the TIPS teaching program; and, for the last 10 years she has coordinated the CSCC Educational Roundtable teleconferences with Dr. Paul Yip from UHN, for approximately 44 Canadian laboratory sites and 250 participants biweekly. Her service and research interests include cardiac markers, protein electrophoresis, testosterone measurement in hypogonadism, eGFR in CKD, test utilization management, and the importance of biological variation and result uncertainty in result interpretation. Dr. Collier has been active in the OSCC, CSCC, Upstate New York Section of the AACC and the IATDMCT. Recently, she completed a Masters in Community Health and Epidemiology (Public Health Sciences) at Queen’s University, and enjoyed a sabbatical in the UK and Australia. Dr. Collier is currently Co-Chair of the CSCC Working Group on Harmonization of Reference Intervals with Dr. Khosrow Adeli from HSC.
Dr. Collins obtained her MD at Queen’s University and completed her Internal Medicine internship and General Pathology residency there. After five years as an Associate Laboratory Physician at North York General Hospital, she worked at the Peterborough Regional Health Centre for 23 years, where she was the Medical Lead in the Clinical Laboratories, and Chair of the Transfusion Committee. She is also the Laboratory Medical Director at the Northumberland Hills Hospital in Cobourg.
In November 2013 she joined the Ontario Regional Blood Coordinating Network (ORBCoN) as the Physician Clinical Projects Coordinator. She Chairs the Ontario Contingency Planning Committee for blood shortages, serves on other provincial committees related to transfusion medicine, and is a peer assessor for the College of Physicians and Surgeons of Ontario.
Dr. Downes graduated from the Royal College of Surgeons in Ireland medical school with first class honours and undertook training in surgery leading to her Membership of the Royal College of Surgeons (MRCSI). Following this she completed a two year research fellowship in prostate cancer at University College Dublin and was awarded her Doctor of Medicine (MD) by thesis. She trained in Anatomic Pathology in Dublin, Ireland and then completed a clinical fellowship in genitourinary pathology at the University Health Network, Toronto during which time she was awarded FRCPC. She practices as a genitourinary pathologist at Sunnybrook Health Sciences Centre in Toronto. She is an assistant professor in Laboratory Medicine and Pathobiology at the University of Toronto. Her research and publications focus on prostate and bladder malignancy. She is a peer reviewer for Histopathology and Journal of Clinical Pathology and is an editorial board member of Human Pathology: Case Reports
Annette Ellenor is the Manager for the Pathology Quality Management Program at Cancer Care Ontario; her portfolio is focused on supporting the design and implementation of a quality management program for surgical pathology across Ontario.
She comes to the QMP from the field of nursing with extensive experience in intensive care. She has worked the nursing college in areas of clinical education and evaluation. She has brought a comprehensive clinical background and extensive project management skills to the pathology QMP since it’s inception in 2013.
Dr. Andrew Evans is a Staff Pathologist and consultant in Genitourinary Pathology at University Health Network (UHN) in Toronto, Ontario, Canada. He is an Associate Professor in the Department of Laboratory Medicine and Pathobiology at The University of Toronto and an active participant in translational and clinical research carried out by the uro-oncology program at UHN. He has been a member of several guideline committees for genitourinary cancers including Cancer Care Ontario (CCO) expert panels on prostate biopsies, radical prostatectomies and active surveillance for prostate cancer and the American Society of Clinical Oncology (ASCO) guideline on the management of small renal masses. He is the current North American Councilor for the International Society of Urological Pathology (ISUP). He has also served as Director of the UHN Telepathology program since its inception in 2003. UHN has successfully integrated digital pathology into patient care for a variety of applications, including frozen sections, consultation and primary diagnosis. He is currently Chair of the College of American Pathologists (CAP) Digital Pathology Committee and Chair of the CAP Pathology and Laboratory Quality Center committee which is revising CAP 2013 guidelines for validating and implementing digital pathology systems for diagnostic purposes.
Dr James Limacher graduated in medicine from the University of Calgary and completed residencies in anatomic pathology at McGill University and Laval University and in clinical pathology at Queen’s University and the University of Vermont. After a decade as a hospital pathologist and laboratory director in Cornwall and northeastern New York State, Dr Limacher completed a fellowship in dermatopathology followed by a residency in dermatology at the University of Oklahoma. He practised as a dermatologist and dermatopathologist in Buffalo, NY before moving to Toronto where he now practices as a dermatopathologist. Dr Limacher holds a faculty appointment at the University of Toronto and teaches in its dermatology residency program.
Volodymyr (Vlad) Maksymov, MD PhD FRCPC
DMD, Lviv State Medical University, Lviv, Ukraine. PhD, Moscow, Russia. Residency: Anatomical Pathology, Memorial University of Newfoundland, St. John’s, Canada. Staff Pathologist, Grand River Hospital & St. Mary’s General Hospital, Regional Hepato-Pancreato-Biliary Center (Kitchener-Waterloo, Ontario, Canada), Clinical Assistant Professor, Discipline of Laboratory Medicine, McMaster University, Hamilton, Ontario, Canada. Interests: Reporting and evaluation of the margins in pancreaticoduodenectomy specimen with emphasis on borderline resectable pancreatic adenocarcinoma with or without preoperative chemoradiation in the correlation with multimodality imaging.
Dr. Marginean has a number of local, provincial and national leadership roles: she is the Head of Gastrointestinal (GI) Pathology Section and Deputy Head of Cytopathology Section at Ottawa Hospital. She is part of several committees: Canadian Partnership Against Cancer , GI Endoscopy Steering Committee- Champlain LHIN, Communities of Practice Champlain LHIN (thyroid, colorectal), USCAP and OAP. Her research interests are mainly in GI cancers, including pancreatic, CRC, gastric, esophageal and neuroendocrine tumours (NET) .She has been an invited speaker at numerous meetings, national and international.
Dr. Jelena Mirkovic, originally from Belgrade, Serbia, is an anatomic pathologist with subspecialties in gynecologic pathology and cytology who is practicing at Sunnybrook Health Sciences Centre, Toronto, ON. She completed Anatomic Pathology residency, Women’s and Perinatal Pathology fellowship, and Cytopathology fellowship at the Brigham and Women’s Hospital/Harvard Medical School, Boston, Massachusetts, USA. She also received a PhD degree from Harvard/Massachusetts Institute of Technology Division of Health Sciences and Technology. Her current research interests include minimally invasive diagnosis of cancer and its precursors using quantum information technology and also span a wide variety of gynecologic diseases such as mesonephric lesions of the female genital tract, cervical neoplasia, soft tissue tumors of the vulva, gestational trophoblastic tumors, and adolescent endometriosis.
Dr. Aaron Pollett is an Anatomic Pathologist and co-director of the Division of Diagnostic Medical Genetics at Mount Sinai Hospital. He is an Associate Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto and is the current Provincial Head of the Pathology and Laboratory Medicine Program at Cancer Care Ontario.
Aaron has a speciality interest in gastrointestinal pathology and pathology informatics, particularly in the area of colorectal cancer and biomarker implementation. He is the review pathologist for the Familial Gastrointestinal Cancer Registry (FGICR) and the Ontario Familial Colon Cancer Registry (OFCCR), tumour based registries constructed to analyze the genetic basis of gastrointestinal cancers.
- Doctor of Medicine, University of Ottawa
- Fellowship in General Pathology, Queen’s University
- Chief of Pathology, Royal Victoria Regional Health Centre 1998-2014
- Medical Director of Laboratories, Royal Victoria Regional Health Centre 1998-present
- Assistant Clinical Professor, Pathology and Molecular Medicine, McMaster University
- Clinical Adjunct Professor, Pathology and Laboratory Medicine, Western University
Dr. Raphael completed his medical education at the University of Western Ontario and completed his residency at UWO as well. He did specialty training in Endocrine Pathology at the UofT.
He also holds an M Ed from the UofT.
His past positions included Deputy Chief of Pathology at Sunnybrook HSC in Toronto, Residency Program Director of Anatomical Pathology at UofT and Examiner for the RCPSC.
He is currently the Chief of Pathology at North York General Hospital in Toronto and Associate Professor at UofT. He is LHIN regional lead for the QMP program and co-heads the Hospital Quality Committee at NYGH. He is Vice Chair of the MAC at the same institution. He is also an Assessor for the CPSO in Pathology.
Bekim Sadikovic, PhD, DABMG, FACMG, is Associate Professor of Pathology and Laboratory Medicine at the Western University, and Head of Molecular Genetics at the London Health Sciences and St Joseph’s Healthcare in Ontario Canada. Dr Sadikovic is a diplomate of the American Board of Medical Genetics from Baylor College of Medicine and holds American Board of Medical Genetics certifications in Clinical Molecular Genetics and Clinical Cytogenetics. Prior to his appointment at the Western University, Dr. Sadikovic served as the Head of Advanced Molecular Diagnostics at the McMaster University. Dr. Sadikovic’s research interests revolve around application of genomics technologies to clinical diagnostics with particular focus on development of genomic and epigenomic technologies for diagnosis of both germ-line and somatic epi/genetic conditions. His current research specifically focuses on identification of epi/genetic signatures of constitutional genetic and epigenetic syndromes, and development of analytical and bioinformatic approaches for parallel detection of copy number and sequence variations from NGS data. In chis clinical role Dr Sadikovic oversees the provincial reference Molecular Genetics laboratory performing constitutional, prenatal, and somatic genomic testing across wide range of genomic disorders in Ontario, Canada.
Dr. Tsao is a Consultant Thoracic Pathologist, Senior Scientist and M. Qasim Choksi Chair in Lung Cancer Translational Research at the Princess Margaret Cancer Centre, Toronto, Canada. He is a Professor of Laboratory Medicine and Pathobiology, and Professor of Medical Biophysics at the University of Toronto. Dr. Tsao is the co-chair of the Correlative Science and Tumor Biology Committee of the Canadian Cancer Clinical Trials Group (CCTG), and a member of the Executive Committee of Lung Cancer Disease site. He is a member and Past Chair (2011-13) of the International Association for the Study of Lung Cancer (IASLC) Pathology Committee, a current member of the IASLC Staging and Prognostic Factor Committee, and the lead co-editor of the IASLC Atlas of ALK and ROS1 Testing in Lung Cancer, and IASLC PD-L1 Testing in Lung Cancer. Dr. Tsao received the 2011 O. Harold Warwick Award from the Canadian Cancer Society, the 2015 Mary Matthew Pathology Award from IASLC, and the 2016 Dr. Joseph Pater Founder’s Award for Excellence in Clinical Trials Research from CCTG. He is the lead author for the chapter on Squamous cell carcinoma in the 2015 WHO Classification of Lung, Pleura, Thymus and Heart Neoplasms.